Simeprevir, buon controllo delle infezioni ricorrenti da HCV dopo trapianto epatico [Gastro]
Pharmastar Italy,
La tripla terapia a base di simeprevir è sicura ed efficacia nelle prime 12 settimane, nella maggior parte dei soggetti, con…
Use of simeprevir following pre‐emptive pegylated interferon/ribavirin treatment for recurrent hepatitis C in living donor liver transplant recipients: a 12‐week pilot study
Overview of attention for article published in Journal of Hepato-Biliary-Pancreatic Sciences, October 2014
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (85th percentile)
-
High Attention Score compared to outputs of the same age and source (80th percentile)
Readers on
- mendeley
- 17 Mendeley